Related Experiment Video
Updated: Aug 18, 2026

The Examination of Peroxidase-Positive Leukocytes in Semen
Published on: January 19, 2024
Myeloperoxidase and cardiovascular disease
Stephen J Nicholls1, Stanley L Hazen
1Department of Cardiovascular Medicine and Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Abstract:
Myeloperoxidase (MPO) is a leukocyte-derived enzyme that catalyzes the formation of a number of reactive oxidant species. In addition to being an integral component of the innate immune response, evidence has emerged that MPO-derived oxidants contribute to tissue damage during inflammation. MPO-catalyzed reactions have been attributed to potentially proatherogenic biological activities throughout the evolution of cardiovascular disease, including during initiation, propagation, and acute complication phases of the atherosclerotic process. As a result, MPO and its downstream inflammatory pathways represent attractive targets for both prognostication and therapeutic intervention in the prophylaxis of atherosclerotic cardiovascular disease.
Insights
Myeloperoxidase (MPO) is an enzyme involved in inflammation and tissue damage. Targeting MPO and its pathways may help prevent cardiovascular disease progression.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Medicine
Background:
- Myeloperoxidase (MPO) is an enzyme produced by leukocytes.
- MPO generates reactive oxidants, playing a role in innate immunity.
- MPO-derived oxidants are implicated in tissue damage during inflammation.
Purpose of the Study:
- To explore the role of MPO in cardiovascular disease.
- To identify MPO as a potential target for cardiovascular disease treatment.
Main Methods:
- This study reviews existing evidence on MPO's role in atherosclerosis.
- Analysis of MPO-catalyzed reactions and their impact on cardiovascular disease progression.
Main Results:
- MPO-catalyzed reactions contribute to proatherogenic activities.
- These activities span all phases of atherosclerosis, from initiation to complications.
Conclusions:
- MPO and its inflammatory pathways are key players in cardiovascular disease.
- MPO presents a promising target for cardiovascular disease prognostication and therapy.
More Related Videos
05:17Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Peroxisomes
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...